List of Morphine Sulfate drug patents

Morphine Sulfate is owned by Fresenius Kabi Usa.

Morphine Sulfate contains Morphine Sulfate.

Morphine Sulfate has a total of 3 drug patents out of which 0 drug patents have expired.

Morphine Sulfate was authorised for market use on 30 October, 2013.

Morphine Sulfate is available in solution;intramuscular, intravenous dosage forms.

Morphine Sulfate can be used as management of chronic pain in patients requiring opioid analgesia; treatment of pain.

The generics of Morphine Sulfate are possible to be released after 12 March, 2034.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9192608 FRESENIUS KABI USA Morphine formulations
Mar, 2034

(11 years from now)

US9248229 FRESENIUS KABI USA Packaging system for oxygen-sensitive drugs
Mar, 2034

(11 years from now)

US9072781 FRESENIUS KABI USA Morphine formulations
Mar, 2034

(11 years from now)

Drugs and Companies using MORPHINE SULFATE ingredient

Market Authorisation Date: 30 October, 2013

Treatment: Management of chronic pain in patients requiring opioid analgesia; Treatment of pain

Dosage: SOLUTION;INTRAMUSCULAR, INTRAVENOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in